Adventist Health System/ West
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 18, 2026), Adventist Health System/ West reported 8 stock positions worth $595.0 million. Its top holding was iShares Core S&P 500 ETF (IVV) at 51.7% of the portfolio, followed by Vanguard Ftse Developed ETF (VEA, 11.9%) and Vanguard Russell 1000 Value (VONV, 10.7%). Compared with Q3 2025, it opened 1 new position, sold out of 1 and reduced 2. The biggest buy was a new position in iShares Core S&P 500 ETF (IVV) and the biggest sale an exit from Vanguard S&P 500 ETF (VOO).
- Most Recent 13F
- Q2 2026
- Location
- Roseville, CA
- CIK
- 0001802516
- Portfolio Value
- $595.0M (Q4 2025)
- SEC Filing
- 0001172661-26-001286 ↗ filed Feb 18, 2026
Holdings Value
Holdings 8 stocks · $595.0M
| IVV iShares Core S&P 500 ETF | 51.65% | 448,668 | $307.3M | New |
| VEA Vanguard Ftse Developed ETF | 11.88% | 1,131,440 | $70.7M | No change |
| VONV Vanguard Russell 1000 Value | 10.75% | 692,800 | $63.9M | No change |
| ITOT iShares Core S&P Total U.S. | 8.03% | 321,151 | $47.8M | Reduce -30.2% |
| VTIP Vanguard Short-Term Tips | 6.37% | 766,010 | $37.9M | No change |
| IXUS iShares Core Intl Stock ETF | 4.85% | 340,741 | $28.8M | Reduce -26.3% |
| VOT Vngrd Mrngstr MC GRW ETF-Usd | 4.54% | 96,768 | $27.0M | No change |
| VBK Van Morst SML-Cap Gro-Usd Inc. | 1.94% | 38,149 | $11.5M | No change |
Portfolio Sells Q3 2025 → Q4 2025
Portfolio Buys Q3 2025 → Q4 2025
| IVV iShares Core S&P 500 ETF | New | 51.65% | +51.65 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $638.1M | IVV, VEA, VONV, IXUS, ITOT |
| Q1 2026 | 13 | $563.9M | IVV, VEA, VONV, IXUS, ITOT |
| Q4 2025 | 8 | $595.0M | IVV, VEA, VONV, ITOT, VTIP |
| Q3 2025 | 8 | $613.9M | VOO, VEA, ITOT, VONV, VTIP |
| Q2 2025 | 8 | $673.3M | VOO, IVV, VEA, VONV, EMXC |
| Q1 2025 | 8 | $633.7M | VOO, IVV, IEMG, VEA, VONV |
| Q4 2024 | 8 | $646.5M | VOO, IVV, VONV, IEMG, VEA |
| Q3 2024 | 7 | $650.2M | IVV, IEMG, VEA, VONV, VTIP |
| Q2 2024 | 7 | $615.9M | IVV, IEMG, VEA, VONV, VTIP |
| Q1 2024 | 5 | $556.2M | IVV, IEFA, IEMG, VONV, VTIP |